Diff Profiles › MTBLS2406_0001_00000009

Control_vs_nsPEF_7_day

Control vs nsPEF_7_day

p-value ≤ 0.05 739 significant 2025-09-26 00:00:00 Study: MTBLS2406
2383 Total Features
739 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS2406_0001_00000009
Linked study
MTBLS2406 — Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
Comparison
Control vs nsPEF_7_day
Group A
Control group with no treatment. Serves as the reference point for all treatment comparisons
Group B
Samples treated with nsPEF for 7 days. Represents long-term response to nsPEF treatment
Total features tested
2383
Significant features
739
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
CZEXQBQCMOVXGP-NSHDSACASA-N (2S)-2-hydrazinyl-3-(4-hydroxy-3-methoxyphenyl)-2-methylpropanoic acid down 1.36e-10 3.65e-11
LDQNIBPJKBVZEF-UHFFFAOYSA-N 8,17-dihydroxy-6,19-dimethoxy-14,14-dimethyl-3,15-dioxapentacyclo[11.6.1.02,11.04,9.016,20]icosa-1(19),2(11),4,6,8,16(20),17-heptaen-10-one down 1.069e-09 3.34e-12
CQLSQWAVFSEMIE-UHFFFAOYSA-N 2-[4,5-dihydroxy-6-(hydroxymethyl)piperidin-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol down 2.409e-10 2.74e-10
RWCOTTLHDJWHRS-YUMQZZPRSA-N P-P down 2.218e-10 1.96e-09
NOLPUILTGZBYGW-UHFFFAOYSA-N 6-[6-[(2-carboxyacetyl)oxymethyl]-2,4,5-trihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid down 2.44e-09 5.56e-10
ZLIBICFPKPWGIZ-UHFFFAOYSA-N 4,6-Dimethyl-N-phenyl-2-pyrimidinamine down 1.313e-10 1.62e-08
QOLYAJSZHIJCTO-UHFFFAOYSA-N 1-(2-amino-3-hydroxybutanoyl)pyrrolidine-2-carboxylic acid down 1.682e-09 3.23e-08
WSEQXVZVJXJVFP-FQEVSTJZSA-N <i>S</i>(+)-citalopram down 2.266e-10 5.82e-07
GJZJZRWFRZFTEE-ONEGZZNKSA-N 2-[2-[(E)-pent-2-enyl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclopentyl]acetic acid down 1.741e-10 8.45e-07
HUJXHFRXWWGYQH-UHFFFAOYSA-O Sinapoylcholine down 2.159e-09 3.58e-06